Ifp Advisors, Inc Nkarta, Inc. Transaction History

Ifp Advisors, Inc

$2.91 Billion
Q4 2024

A detailed history of Ifp Advisors, Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2 shares of NKTX stock, worth $4. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	BUY	$2.17 - $4.34 $4 - $8	2 New	2 $0
Q3 2021 Oct 06, 2021	SELL	$26.67 - $38.76 $10,668 - $15,504	-400 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$23.94 - $36.68 $9,576 - $14,672	400 New	400 $13,000

Others Institutions Holding NKTX

# of Institutions

120

Shares Held

61.3M

Call Options Held

17.6K

Put Options Held

1.11M

Ra Capital Management, L.P. Boston, MA

10.8M
Shares

$22.2 Million
0.44% of portfolio
Black Rock Inc. New York, NY

4.06M
Shares

$8.32 Million
0.0% of portfolio
Samsara Bio Capital, LLC Palo Alto, CA

3.77M
Shares

$7.72 Million
2.88% of portfolio
Nea Management Company, LLC Timonium, MD

3.57M
Shares

$7.32 Million
0.63% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

3.56M
Shares

$7.31 Million
0.0% of portfolio

View Full List

About Nkarta, Inc.

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $99.7M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

More about NKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account